These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8722337)

  • 61. Allogeneic marrow reconstitution using peripheral blood stem cells: the dawn of a new era.
    Lane TA
    Transfusion; 1996 Jul; 36(7):585-9. PubMed ID: 8701452
    [No Abstract]   [Full Text] [Related]  

  • 62. Graft-versus-host-disease and granulocyte colony-stimulating factor administration after allogeneic stem cell transplantation.
    Mohty M; Faucher C; Blaise D
    Leukemia; 2005 Apr; 19(4):500-3. PubMed ID: 15674410
    [No Abstract]   [Full Text] [Related]  

  • 63. CD34 stem cell dose and development of extensive chronic graft-versus-host disease.
    Handgretinger R; Lang P; Klingebiel T; Niethammer D
    Blood; 2002 May; 99(10):3875-6; author reply 3876-7. PubMed ID: 12014372
    [No Abstract]   [Full Text] [Related]  

  • 64. Role of natural killer cells in the development of graft-versus-host disease.
    Bryson JS; Flanagan DL
    J Hematother Stem Cell Res; 2000 Jun; 9(3):307-16. PubMed ID: 10894352
    [No Abstract]   [Full Text] [Related]  

  • 65. The place of blood stem cells in allogeneic transplantation.
    Russel N; Gratwohl A; Schmitz N
    Br J Haematol; 1996 Jun; 93(4):747-53. PubMed ID: 8703799
    [No Abstract]   [Full Text] [Related]  

  • 66. Allogeneic peripheral blood stem cell transplantation.
    Buckner CD; Bensinger WI
    Rinsho Ketsueki; 1997 Mar; 38(3):157-61. PubMed ID: 9095648
    [No Abstract]   [Full Text] [Related]  

  • 67. Peripheral blood stem cells for allografting.
    Goldman J
    Blood; 1995 Mar; 85(6):1413-5. PubMed ID: 7534129
    [No Abstract]   [Full Text] [Related]  

  • 68. Granulocyte transfusions - bridging to allogeneic hematopoietic stem cell transplantation.
    Nguyen TM; Scholl K; Idler I; Wais V; Körper S; Lotfi R; Bommer M; Wiesneth M; Schrezenmeier H; Döhner H; Bohl SR; Harsdorf SV; Reinhardt P; Bunjes D; Ringhoffer M; Kuchenbauer F
    Leuk Lymphoma; 2020 Feb; 61(2):481-484. PubMed ID: 31547738
    [No Abstract]   [Full Text] [Related]  

  • 69. [Grafts from non-related voluntary donors. Experiences and results at the hospital Saint-Louis].
    Devergie A
    Soins; 1989; (526-527):28-9. PubMed ID: 2814606
    [No Abstract]   [Full Text] [Related]  

  • 70. Effect of alpha IFN on unaggressive immunoproliferative disorders.
    Frigeri F; De Renzo A; Marcenò R; Ruggeri P; Musto P; Andriani A; Citarrella P; Caronia F; Rotoli B
    Haematologica; 1995; 80(1):35-9. PubMed ID: 7758989
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Atypical immunoproliferative disorders: when of age?
    Frizzera G
    Virchows Arch A Pathol Anat Histopathol; 1993; 422(4):261-3. PubMed ID: 8506619
    [No Abstract]   [Full Text] [Related]  

  • 72. Primed marrow for autologous and allogeneic transplantation: a review comparing primed marrow to mobilized blood and steady-state marrow.
    Elfenbein GJ; Sackstein R
    Exp Hematol; 2004 Apr; 32(4):327-39. PubMed ID: 15050742
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Allogeneic transplantation for hematological malignancies using rho G-CSF mobilized blood stem cells.
    Azevedo WM; Aranha FJ; Gouvea JV; Vigorito AC; Marques JF; Eid KA; Azevedo AM; Barbosa KB; Souza CA
    Bone Marrow Transplant; 1996 Mar; 17 Suppl 2():S54-5. PubMed ID: 8722337
    [No Abstract]   [Full Text] [Related]  

  • 74. Transplantation of allogeneic peripheral blood stem cells.
    Bensinger WI; Buckner CD; Demirer T; Storb R; Appelbaum FA
    Bone Marrow Transplant; 1996 Mar; 17 Suppl 2():S56-7. PubMed ID: 8722338
    [No Abstract]   [Full Text] [Related]  

  • 75. [A pilot study of G-CSF mobilized allogeneic bone marrow cells plus peripheral blood stem cells transplantation for malignant hematological diseases].
    Chen Y; Huang X; Xu L; Liu D; Zhang Y; Ren H; Guo N; Lu D
    Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(19):1306-9. PubMed ID: 12509932
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Chronic graft-versus-host disease after granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation: the role of donor T-cell dose and differentiation.
    MacDonald KP; Rowe V; Filippich C; Johnson D; Morris ES; Clouston AD; Ferrara JL; Hill GR
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):373-85. PubMed ID: 15148491
    [TBL] [Abstract][Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.